USD/CAD Price Forecast: Trades firmly near 50% Fibo retracement at 1.3760, Canada CPI data awaited
The USD/CAD pair trades marginally higher to near 1.3750 during the European trading session on Tuesday. The Loonie pair ticks up as the US Dollar (USD) reflects strength due to firm expectations that the Federal Reserve (Fed) will either hold interest rates at their current levels for longer or raise them this year.
During the press time, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, trades 0.15% higher to near 99.10.
The CME FedWatch tool shows that the possibility of the Fed holding interest rates at their current levels by the year-end is 53%, while the rest favor at least one interest rate hike this year.
Though investors have underpinned the US Dollar against the Canadian Dollar (CAD), the latter outperforms its other peers ahead of Canada’s Consumer Price Index (CPI) data for April, which will be published at 12:30 GMT. The CPI report is expected to show that the headline inflation accelerated to 3.1% Year-on-Year (YoY) from 2.4% in March. Signs of price pressures accelerating would prompt expectations for interest rate hikes by the Bank of Canada in the near term.
USD/CAD technical analysis
USD/CAD trades slightly higher at around 1.3750, holding a mildly bullish near-term bias as it consolidates above the 20-day exponential moving average (EMA) at 1.3701, though struggles to extend its advance above the 50% Fibonacci retracement at 1.3760.
The Relative Strength Index (RSI) at 57 keeps a positive, yet not overbought, tone that hints at persistent upside pressure as long as these supports hold.
On the topside, immediate resistance emerges at the 50.0% Fibo retracement, followed by the 61.8% level at 1.3809, with further barriers at 1.3880 and the recent cycle high around 1.3970. On the downside, initial support is seen around the 20-day EMA at 1.3701 and the 38.2% retracement at 1.3710, with deeper cushions at the 23.6% level at 1.3649 and the swing low zone near 1.3550, where buyers would be expected to defend the broader uptrend.
(The technical analysis of this story was written with the help of an AI tool.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Qualcomm (QCOM.US) Snapdragon Summit Preview: 2nm Dual-Chip Debuts, AI Diversification Narrative Faces Key Verification
Qualcomm is scheduled to hold its annual Snapdragon Summit in Maui, Hawaii, from September 22 to 24 local time.
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

